Plasma volume and oncotic pressure (COP)

Plasma volume represents the liquid portion of the blood, while oncotic pressure (colloid osmotic pressure) is the specific osmotic pressure exerted by proteins, notably albumin, within the vascular compartment (StatPearls, 2023). Together, they are fundamental components of the Starling equation, which describes the net filtration of fluid across capillary membranes into the interstitium (NCBI, 2022). Maintaining these parameters is vital for ensuring adequate tissue perfusion and preventing the accumulation of excess fluid in tissues, known as edema. In therapeutic contexts, plasma volume and oncotic pressure are manipulated through the administration of intravenous fluids, including crystalloids and colloids, to manage conditions such as hypovolemic shock, sepsis, and hypoalbuminemia (Merck Manual, 2024). Although not a single protein or receptor, the management of these physiological states is a cornerstone of critical care and emergency medicine. Drugs like human albumin directly increase oncotic pressure to pull fluid into the vessels, while diuretics like furosemide reduce plasma volume to treat congestion (PubMed, 2021).

Other names

Colloid osmotic pressurePlasma oncotic pressureIntravascular volumeStarling forces

Drugs targeting these parameters work by either increasing the concentration of intravascular osmotically active particles (colloids) to draw fluid into the vasculature or by directly increasing the total fluid volume (crystalloids) (StatPearls, 2023). Diuretics conversely reduce plasma volume by promoting the renal excretion of water and electrolytes (PubMed, 2021).